![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, July 01, 2009 8:07:42 AM
By Jonathan Starkey
Washington Post Staff Writer
Wednesday, July 1, 2009
Shares of the Rockville-based vaccine maker Novavax surged more than 30 percent yesterday on news that the Spanish government plans to use its technology to protect people from the flu.
Through a Spanish Ministry of Health program, Novavax will receive at least $35 million to develop pandemic and seasonal flu vaccines and seek regulatory approval in Europe, said Novavax chief executive Rahul Singhvi. The company is already testing a seasonal flu vaccine on people to determine dosage, and a swine flu vaccine will be in human trials by later this year, Singhvi said.
The company will develop the vaccines with the Spanish drugmaker Rovi Pharmaceuticals, which would have exclusive rights to sell them in Spain and Portugal. Terms of the agreement are still being negotiated.
Novavax will collect royalties on Rovi's sales of the products.
"The real value is in the development dollars that are going to be coming available," Singhvi said. He said the deal gives the company a clear path toward marketing its products. "For a biotech company, that's truly transformational."
Novavax said Rovi will buy $3 million worth of its stock at $2.74 a share. Novavax shares closed up 78 cents yesterday, at $3.28.
The agreement was good news for Novavax, which posted an $8.3 million loss in the first quarter as revenue fell 95 percent. The company said in May that it had enough capital to carry out its business plan for 12 months.
"It alleviates the need to raise 40 to 50 million dollars on their own," Elemer Piros, an analyst at Rodman & Renshaw, said of the deal.
Unusually, analysts said, Novavax will retain rights to market the vaccines in countries other than Spain and Portugal, including the United States. Normally under such deals, the pharmaceutical company would seek worldwide rights.
"Normally, you would get a greater upfront payment, and then the company that conducts the trials will basically have full rights and just give a royalty," said Brian Abrahams, an analyst at Oppenheimer who follows Novavax.
The companies hope to seek European approval in 2012.
"The Spanish government thinks that in the future, whether we're dealing with seasonal flu, bird flu, swine flu, they will protect their people based on Novavax technology," Piros said.
Traditionally, to create flu vaccines, drugmakers grow live virus strains in chicken eggs, which act as incubators. The virus is later killed and bottled into a vaccine.
Novavax uses particles that mimic the virus but lack the genetic material. After identifying a pandemic strain, the technology allows Novavax to produce a vaccine in half the time it takes to make an egg-based vaccine.
Recent NVAX News
- Novavax to Participate in Upcoming September Conferences • PR Newswire (US) • 09/04/2024 01:25:00 PM
- Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. • PR Newswire (US) • 08/30/2024 08:19:00 PM
- Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. • PR Newswire (US) • 08/30/2024 07:46:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 08:47:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 09:06:20 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/08/2024 08:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:04:56 PM
- Novavax Reports Second Quarter 2024 Financial Results and Operational Highlights • PR Newswire (US) • 08/08/2024 12:02:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:37:07 AM
- U.S. Index Futures Drop, Signaling Ongoing Market Volatility; Oil Prices Stall • IH Market News • 08/08/2024 09:55:44 AM
- Novavax to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Operational Highlights on August 8, 2024 • PR Newswire (US) • 08/01/2024 01:25:00 PM
- ASML Rises 7% on Export Waiver; Intel Plans Layoffs, HSBC $3B Buyback Announced, and More • IH Market News • 07/31/2024 09:55:50 AM
- Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine • PR Newswire (Canada) • 07/02/2024 12:30:00 PM
- Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine • PR Newswire (US) • 06/24/2024 01:18:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/18/2024 08:09:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/17/2024 08:13:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:14:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:11:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:10:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:07:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:06:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:05:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:01:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:00:42 PM
- Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine • PR Newswire (US) • 06/14/2024 06:05:00 PM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM